Perspective
This Is What’s at Stake if U.S. Drug Prices Fall — and Europeans Don’t Pay More
February 1, 2018
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD
Research
All Research Featured Research
News
Trump Said Global Drug Pricing Isn’t Fair – Schaeffer Research Explains Why
January 30, 2018
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD
White Paper
The Global Burden of Medical Innovation
January 13, 2018
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD
White Paper
Reining in Pharmaceutical Costs
January 13, 2018
Featured Experts: Karen Van Nuys, PhD, Dana Goldman, PhD
Journal Article
PCSK9 Inhibitors Show Value for Patients and the US Health Care System
January 1, 2018
Featured Experts: Dana Goldman, PhD
Perspective
Follow the Money to Understand How Drug Profits Flow
December 15, 2017
Featured Experts: Neeraj Sood, PhD, Dana Goldman, PhD, Karen Van Nuys, PhD
Perspective
Treatment-Specific Payment Approaches: The Case Of Macular Degeneration
November 27, 2017
Featured Experts: Paul Ginsburg, PhD
Perspective
Pharmaceutical Industry Profits and Research and Development
November 13, 2017
Featured Experts: Paul Ginsburg, PhD
Perspective
Tying Reimbursement to Outcomes Is an Ideal Strategy for PCSK9 Inhibitors
October 31, 2017
Featured Experts: Dana Goldman, PhD
Perspective
Switch and Save on Medicare Part D
October 10, 2017
Featured Experts: Daniel McFadden, PhD
Perspective
A Billion Here, a Billion There: Selectively Disclosing Actual Generic Drug Prices Would Save Real Money
September 12, 2017
Featured Experts: Steven M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
Perspective
Innovative Drugs Deserve Innovative Pricing
August 31, 2017
Featured Experts: David Agus, MD, Dana Goldman, PhD
Journal Article
The Price May Not Be Right: The Value of Comparison Shopping for Prescription Drugs
July 29, 2017
Featured Experts: Sanjay Arora, MD, Sophie Terp, MD, MPH, Neeraj Sood, PhD, Geoffrey Joyce, PhD
White Paper
Would Price Transparency for Generic Drugs Lower Costs for Payers and Patients?
June 14, 2017
Featured Experts: Steven M. Lieberman, MPhil, MA, Paul Ginsburg, PhD
Perspective
Follow the Money: The Flow of Funds in the Pharmaceutical Distribution System
June 13, 2017
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD, Dana Goldman, PhD
News
New Report Documents the Flow of Money Through the Pharmaceutical Distribution Chain
June 13, 2017
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD, Dana Goldman, PhD
Perspective
Value-Based Drug Pricing Makes Sense, But is Difficult to Pull Off
June 8, 2017
Featured Experts: Dana Goldman, PhD
White Paper
Flow of Money Through the Pharmaceutical Distribution System
June 6, 2017
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD, Dana Goldman, PhD